These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 25812824)
1. Comparison of biomarkers between PLA2RAb+ and PLA2RAb- in patients with idiopathic membranous nephropathy. Xun C; shuai L; Wang W; Jiang Y Int Urol Nephrol; 2015 May; 47(5):831-5. PubMed ID: 25812824 [TBL] [Abstract][Full Text] [Related]
2. Detection and clinical significance of glomerular M-type phospholipase A Liu H; Luo W; Gong S; Ding X Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390 [TBL] [Abstract][Full Text] [Related]
3. Altered expression of serum miR-106a, miR-19b, miR-17, and PTEN in patients with idiopathic membranous nephropathy. Wu L; Zhang X; Luo L; Li X; Liu Y; Qin X J Clin Lab Anal; 2021 Apr; 35(4):e23737. PubMed ID: 33745222 [TBL] [Abstract][Full Text] [Related]
4. Serum phospholipase A2 receptor antibodies and immunoglobulin G subtypes in adult idiopathic membranous nephropathy: Clinical value assessment. Cheng G; Liu J; Gilbert A; Cao Y; An C; Lv Z; Wang C; Nie R; Zhang J; Liu Y; Xia M; Li S; Cai H; Li Y; Li Y; Qin X Clin Chim Acta; 2019 Mar; 490():135-141. PubMed ID: 30605630 [TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of detection of plasma and urine IgG4 in idiopathic membranous nephropathy]. Li J; Qu Z; Zhang YM; Yu F; Huang J; Yang R; Zhao MH; Liu G Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 42(6):671-4. PubMed ID: 21170098 [TBL] [Abstract][Full Text] [Related]
6. Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy. Hihara K; Iyoda M; Tachibana S; Iseri K; Saito T; Yamamoto Y; Suzuki T; Wada Y; Matsumoto K; Shibata T PLoS One; 2016; 11(6):e0158154. PubMed ID: 27355365 [TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy]. Wu X; Wen S; Zhu X; Yuan S; Xu X; Yang D; Sun L; Liu H; Liu F Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 42(4):395-399. PubMed ID: 28490696 [TBL] [Abstract][Full Text] [Related]
8. Phospholipase A2 Receptor Antibody IgG4 Subclass Improves Sensitivity and Specificity in the Diagnosis of Idiopathic Membranous Nephropathy. Huang B; Zhang Y; Wang L; Xu W; Zhang J; Zhang Q; Sheng H; Hu Z Kidney Blood Press Res; 2019; 44(4):848-857. PubMed ID: 31242492 [TBL] [Abstract][Full Text] [Related]
9. IgG4-related membranous nephropathy with high blood and low urine IgG4/IgG ratio: a case report and review of the literature. Li XL; Yan TK; Li HF; Xu PC; Jia JY; Wei L; Shang WY; Lin S Clin Rheumatol; 2014 Jan; 33(1):145-8. PubMed ID: 24105363 [TBL] [Abstract][Full Text] [Related]
10. The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy. Tang Z; Wang Y; Tao L; Guo Y; Zheng Y; Zheng D BMC Nephrol; 2018 Dec; 19(1):357. PubMed ID: 30541470 [TBL] [Abstract][Full Text] [Related]
11. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555 [TBL] [Abstract][Full Text] [Related]
12. Validation of a phospholipase A2 receptor antibody ELISA in an Australian cohort with membranous glomerulonephritis. Ong L; Silvestrini R; Chapman J; Fulcher DA; Lin MW Pathology; 2016 Apr; 48(3):242-6. PubMed ID: 27020499 [TBL] [Abstract][Full Text] [Related]
13. Serum Anti-PLA2R Antibody Predicts Treatment Outcome in Idiopathic Membranous Nephropathy. Wei SY; Wang YX; Li JS; Zhao SL; Diao TT; Wang Y; Wang C; Qin Y; Cao Y; Wei Q; Li B Am J Nephrol; 2016; 43(2):129-40. PubMed ID: 27058841 [TBL] [Abstract][Full Text] [Related]
14. Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy. Xu NX; Xie QH; Sun ZX; Wang J; Li Y; Wang L; Liu SJ; Xue J; Hao CM Chin Med J (Engl); 2017 Apr; 130(8):892-898. PubMed ID: 28397717 [TBL] [Abstract][Full Text] [Related]
15. GDF-15 and sST-2 act as biomarkers of disease severity but not independent predictors in idiopathic membranous nephropathy. Wu L; Luo L; Zhou L; Li N; Qin X Int Immunopharmacol; 2022 Oct; 111():109150. PubMed ID: 36027852 [TBL] [Abstract][Full Text] [Related]
16. [Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?]. Netti GS; Ranieri E G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030016 [TBL] [Abstract][Full Text] [Related]
17. Circulating RBP4 Increase and Its Diagnosis of Chronic Kidney Disease. Xun C; Zhao Y; Wang W; Chen C Ann Clin Lab Sci; 2018 Mar; 48(2):205-207. PubMed ID: 29678848 [TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885 [TBL] [Abstract][Full Text] [Related]
19. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kanigicherla D; Gummadova J; McKenzie EA; Roberts SA; Harris S; Nikam M; Poulton K; McWilliam L; Short CD; Venning M; Brenchley PE Kidney Int; 2013 May; 83(5):940-8. PubMed ID: 23364522 [TBL] [Abstract][Full Text] [Related]
20. PLA2R and membranous nephropathy: A 3 year prospective Australian study. Hill PA; McRae JL; Dwyer KM Nephrology (Carlton); 2016 May; 21(5):397-403. PubMed ID: 26369693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]